Duration of Immunity to Norovirus Gastroenteritis
作者： Kirsten Simmons , Manoj Gambhir , Juan Leon , Ben Lopman
关键词: Transmission (mechanics) 、 Economic benefits 、 Young adult 、 Biology 、 Duration (project management) 、 Demography 、 Immunity 、 Incidence (epidemiology) 、 Norovirus 、 Immunology 、 Vaccination
摘要: The duration of immunity to norovirus (NoV) gastroenteritis has been believed be from 6 months 2 years. However, several observations are inconsistent with this short period. To gain better estimates the NoV, we developed a mathematical model community NoV transmission. was parameterized literature and also fit age-specific incidence data England Wales by using maximum likelihood. We scenarios determine effect unknowns regarding transmission on immunity. In various models, estimated at 4.1 (95% CI 3.2-5.1) 8.7 6.8-11.3) Moreover, calculated that children (<5 years) much more infectious than older adults. If vaccine can achieve protection for natural indicated our results, its potential health economic benefits could substantial.
cdc.gov
sci-hub.se 参考文章(38)
Aron J Hall, Mariana Rosenthal, Nicole Gregoricus, Sharon A Greene, Jeana Ferguson, Olga L Henao, Jan Vinjé, Ben A Lopman, Umesh D Parashar, Marc-Alain Widdowson, Incidence of acute gastroenteritis and role of norovirus, Georgia, USA, 2004-2005 Emerging Infectious Diseases. ,vol. 17, pp. 1381- 1388 ,(2011) , 10.3201/EID1708.101533
Ben Lopman, Paul Gastañaduy, Geun Woo Park, Aron J Hall, Umesh D Parashar, Jan Vinjé, Environmental transmission of norovirus gastroenteritis. Current Opinion in Virology. ,vol. 2, pp. 96- 102 ,(2012) , 10.1016/J.COVIRO.2011.11.005
Sarah M. Bartsch, Benjamin A. Lopman, Aron J. Hall, Umesh D. Parashar, Bruce Y. Lee, The potential economic value of a human norovirus vaccine for the United States. Vaccine. ,vol. 30, pp. 7097- 7104 ,(2012) , 10.1016/J.VACCINE.2012.09.040
Raphael Dolin, Neil R. Blacklow, Herbert DuPont, Samuel Formal, Robert F. Buscho, Julius A. Kasel, Robert P. Chames, Richard Hornick, Robert M. Chanock, Transmission of Acute Infectious Nonbacterial Gastroenteritis to Volunteers by Oral Administration of Stool Filtrates The Journal of Infectious Diseases. ,vol. 123, pp. 307- 312 ,(1971) , 10.1093/INFDIS/123.3.307
Jacques Le Pendu, Nathalie Ruvoën-Clouet, Elin Kindberg, Lennart Svensson, Mendelian resistance to human norovirus infections. Seminars in Immunology. ,vol. 18, pp. 375- 386 ,(2006) , 10.1016/J.SMIM.2006.07.009
Amanda Reeck, Owen Kavanagh, Mary K. Estes, Antone R. Opekun, Mark A. Gilger, David Y. Graham, Robert L. Atmar, Serological Correlate of Protection against Norovirus-Induced Gastroenteritis The Journal of Infectious Diseases. ,vol. 202, pp. 1212- 1218 ,(2010) , 10.1086/656364
Thomas A. Parrino, David S. Schreiber, Jerry S. Trier, Albert Z. Kapikian, Neil R. Blacklow, Clinical Immunity in Acute Gastroenteritis Caused by Norwalk Agent The New England Journal of Medicine. ,vol. 297, pp. 86- 89 ,(1977) , 10.1056/NEJM197707142970204
Robert L. Atmar, David I. Bernstein, Clayton D. Harro, Mohamed S. Al-Ibrahim, Wilbur H. Chen, Jennifer Ferreira, Mary K. Estes, David Y. Graham, Antone R. Opekun, Charles Richardson, Paul M. Mendelman, Norovirus Vaccine against Experimental Human Norwalk Virus Illness The New England Journal of Medicine. ,vol. 365, pp. 2178- 2187 ,(2011) , 10.1056/NEJMOA1101245
Yu Jing, Yuan Qian, Yunwen Huo, Luo-Ping Wang, Xi Jiang, Seroprevalence against Norwalk-like human caliciviruses in Beijing, China Journal of Medical Virology. ,vol. 60, pp. 97- 101 ,(2000) , 10.1002/(SICI)1096-9071(200001)60:1<97::AID-JMV16>3.0.CO;2-D
Judith Thomas-Crusells, Janet E. McElhaney, M. Teresa Aguado, Report of the ad-hoc consultation on aging and immunization for a future WHO research agenda on life-course immunization Vaccine. ,vol. 30, pp. 6007- 6012 ,(2012) , 10.1016/J.VACCINE.2012.07.025